NovaBay’s NeutroPhase(R) Supports Healing of Chronic Wounds – NASDAQ

EMERYVILLE, Calif., April 19, 2012 (GLOBE NEWSWIRE) — NovaBay® Pharmaceuticals, Inc. (NYSE AMEX:NBY), a biotech company developing novel anti-infective products for the treatment and prevention of microbial infections, today announced its pure …